An open-label extension study of ivacaftor in children with CF and a CFTR gating mutation initiating treatment at age 2–5 years (KLIMB)
- Resource Type
- Article
- Source
- In
Journal of Cystic Fibrosis November 2019 18(6):838-843 - Subject
- Language
- ISSN
- 1569-1993